Cargando…

A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus

BACKGROUND: Foxp3 is a marker for regulatory T cells (Treg cells), but recent studies have shown the plasticity and heterogeneity of CD4(+)Foxp3(+) T cells. This study aimed to examine the phenotype and function of circulating CD4(+)Foxp3(+) T cells in patients with systemic lupus erythematosus (SLE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanaoka, Hironari, Nishimoto, Tetsuya, Okazaki, Yuka, Takeuchi, Tsutomu, Kuwana, Masataka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171795/ https://www.ncbi.nlm.nih.gov/pubmed/32317002 http://dx.doi.org/10.1186/s13075-020-02183-2

Ejemplares similares

An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy?
por: Hanaoka, Hironari, et al.
Publicado: (2014)

IgG4-Related Disease without Overexpression of IgG4: Pathogenesis Implications
por: Nishina, Naoshi, et al.
Publicado: (2012)

Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus
por: Tsai, Yi-Giien, et al.
Publicado: (2023)

Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus
por: Katsuyama, Takayuki, et al.
Publicado: (2018)

A rare association between Fabry’s disease and granulomatosis with polyangiitis: a potential pathogenic link
por: Hanaoka, Hironari, et al.
Publicado: (2014)

An Overlapping Case of IgG4-related Disease and Klinefelter Syndrome with Lupus-like Serological and Neurological Features: A Case Report and Literature Review
por: Takanashi, Satoshi, et al.
Publicado: (2020)

Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus
por: Hanaoka, Hironari, et al.
Publicado: (2019)

Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus
por: Rother, Nils, et al.
Publicado: (2015)

Platelet-Derived Stromal Cell-Derived Factor-1 Is Required for the Transformation of Circulating Monocytes into Multipotential Cells
por: Seta, Noriyuki, et al.
Publicado: (2013)

Cytokine Networks in Systemic Lupus Erythematosus
por: Lee, Hooi-Ming, et al.
Publicado: (2010)

Unique Characteristics of Prepubertal Onset Systemic Lupus Erythematosus
por: Abdwani, R., et al.
Publicado: (2019)

Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis
por: Hirose, Sachiko, et al.
Publicado: (2019)

Follicular Regulatory T Cells in Systemic Lupus Erythematosus
por: Xia, Xin, et al.
Publicado: (2021)

Detection of Circulating B Cells Producing Anti-GPIb Autoantibodies in Patients with Immune Thrombocytopenia
por: Kuwana, Masataka, et al.
Publicado: (2014)

A Unique Case of Systemic Lupus Erythematosus Pelvic Vasculitis
por: Traisak, Pamela, et al.
Publicado: (2016)

Heterogeneity of Stroke in Patients with Systemic Lupus Erythematosus
por: Kitano, Takaya, et al.
Publicado: (2022)

Altered peripheral lymphocyte subsets in untreated systemic lupus erythematosus patients with infections
por: Lu, Zhimin, et al.
Publicado: (2019)

Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus
por: Jin, Xin, et al.
Publicado: (2022)

Expansion of extrafollicular B and T cell subsets in childhood-onset systemic lupus erythematosus
por: Baxter, Ryan M., et al.
Publicado: (2023)

Regulatory T-Cell-Associated Cytokines in Systemic Lupus Erythematosus
por: Okamoto, Akiko, et al.
Publicado: (2011)

Discrepancy between patient and physician in assessment of global severity in early rheumatoid arthritis
por: Kaneko, Yuko, et al.
Publicado: (2012)

Abatacept downregulates Fcγ receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis
por: Fukue, Ryosuke, et al.
Publicado: (2022)

Phenotyping of P105-Negative B Cell Subsets in Patients with Systemic Lupus Erythematosus
por: Koarada, Syuichi, et al.
Publicado: (2012)

The expression of CXCR4/CXCL12 determines subsets of patients in systemic lupus erythematosus
por: Guilpain, Philippe, et al.
Publicado: (2011)

Pathogenesis of Renal Disease in Systemic Lupus Erythematosus—The Role of Autoantibodies and Lymphocytes Subset Abnormalities
por: Yap, Desmond Y. H., et al.
Publicado: (2015)

Proteomics reveals unique identities of human TGF-β-induced and thymus-derived CD4(+) regulatory T cells
por: Mensink, Mark, et al.
Publicado: (2022)

Regulatory T cells in systemic lupus erythematosus: past, present and future
por: Horwitz, David A
Publicado: (2008)

Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus
por: Cham, Candace M., et al.
Publicado: (2012)

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus
por: Mizui, Masayuki, et al.
Publicado: (2018)

Research Progress on Regulatory B Cells in Systemic Lupus Erythematosus
por: Wang, Tao, et al.
Publicado: (2019)

Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus
por: Lyu, Mi-Ae, et al.
Publicado: (2023)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Thymus-Derived, Peripherally Derived, and in vitro-Induced T Regulatory Cells
por: Elkord, Eyad
Publicado: (2014)

T cell subsets and immunoglobulin G levels are associated with the infection status of systemic lupus erythematosus patients
por: Wu, Lifen, et al.
Publicado: (2017)

Th17 is involved in the pathogenesis of Bechet's disease via CCL20-CCR6 axis
por: Yasuoka, Hidekata, et al.
Publicado: (2012)

Evaluation of fetal thymus size in maternal autoimmune diseases: systemic lupus erythematosus, Sjögren’s syndrome and antiphospholipid antibody syndrome
por: Uyan Hendem, Derya, et al.
Publicado: (2023)

Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop
por: Masuda, Ayako, et al.
Publicado: (2013)

Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome
por: Hanaoka, Hironari, et al.
Publicado: (2018)

Shared and Unique Patterns of DNA Methylation in Systemic Lupus Erythematosus and Primary Sjögren's Syndrome
por: Imgenberg-Kreuz, Juliana, et al.
Publicado: (2019)

Reduced Expression of TCR Zeta Is Involved in the Abnormal Production of Cytokines by Peripheral T Cells of Patients with Systemic Lupus Erythematosus
por: Yoshimoto, Keiko, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_didajpoprb3h1e7d2mhrf7bmk1